MIR6795

Across TCGA pan-cancer cohorts, MIR6795 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR6795 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR6795 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6795 expression acts as an unfavorable survival marker.

LUSC, PAAD, and OV are the cancer types where MIR6795 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	II,III,IV	0.124	0.709	<.001	54	view →
PAAD	OS	Tertile	All	0.132	0.590	<.001	36	view →
OV	OS	Tertile	II,III,IV	0.377	0.693	.038	36	view →
LGG	DFS	Tertile	All	0.224	0.738	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR6795–LUSC (DFS)

Open the LUSC breakdown →